ASHLEY KELLEY: Open Payments
NPI 1528554136 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 17 payments from 8 companies in 2025. Trend: 2023 $306 · 2024 $568 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 8 | $82 |
| Cycle Pharmaceuticals Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Amgen Inc. | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Vifor Pharma, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Venxxiva, JYNARQUE, TAVNEOS, HYMOVIS, Veltassa, FARXIGA.
Industry payments across MO — which companies pay providers there.
